CDTX

Cidara Therapeutics, Inc. is a forward-thinking biotechnology firm headquartered in San Diego, California, focused on advancing long-acting anti-infective therapies to tackle critical unmet medical needs in infectious diseases. Utilizing its proprietary Cloudbreak™ platform, Cidara is at the forefront of developing innovative treatments that aim to improve patient outcomes and increase treatment adherence. The company's diverse pipeline encompasses promising therapeutics targeting both fungal and bacterial infections, strategically positioning it within the dynamic landscape of infectious disease management and underscoring its commitment to enhancing global health.